New OCD Treatment Approved In Europe
Posted on: Wednesday, 15 July 2009, 06:20 CDT
On Tuesday, Medtronic Inc. said that it received regulatory approval in Europe for an implantable brain simulator to treat patients that suffer from obsessive-compulsive disorder.
The company, which is based out of Minneapolis, said the approval marks the first time any type of deep brain simulation has gained CE Mark approval for treatment of a psychiatric disorder.
The battery-powered device is implanted near the collarbone or abdomen, and is then connected by a wire to electrodes placed in the brain.
It received U.S. approval in February through a humanitarian device exemption. The device's approval allows treatment of a condition affecting less than 4,000 people a year.
OCD is an anxiety disorder that is characterized by constant upsetting thoughts, which causes the person to perform an action repeatedly in an attempt to dispel them.
The neurostimulator, according to Medtronic, is used for its Reclaim Deep Brain Stimulation Therapy. This is also used to treat common movement disorders like Parkinson's disease and dystonia.
The device is similar to a pacemaker because it delivers electrical pulses to targeted areas of the brain.
However, the device will use a unique lead, or wire, because the area of the brain targeted for OCD is different.
Medtronic said it also plans to conduct a post-market study of the therapy at a minimum of eights sites in Europe.
Material was recently published in the journal Molecular Psychiatry from research into DBS therapy for OCD. This article showed the research had a reduction of symptoms and functional improvement in about two-thirds of the patients studied. Medtronic said that a majority of the patients moved from a severe OCD rating to a mild, or moderate, rating after the device was implanted.
Medtronic announced that it is also studying Reclaim DBS therapy in treatment-resistant depression.
---
On the Net:
Source: redOrbit Staff & Wire Reports
Related Articles
- Center for Autism and Related Disorders Study Finds Hyperbaric Oxygen Therapy Ineffective Treatment for Children with Autism
- Upsher-Smith Launches New Website for Divigel(R), a Bioidentical and FDA-Approved Hormone Therapy for Moderate to Severe Hot Flashes, Including Night Sweats, Associated with Menopause
- World's First Deep Brain Stimulation Device Approved for Treatment of Psychiatric Condition in Europe
- Elsevier and Brain Mapping Foundation Co-Host 6th Annual World Congress of IBMISPS on Brain Mapping and Image Guided Therapy
- U.S. Food and Drug Administration (FDA) Approves PREZISTA(R) Once-Daily As Part of Combination Therapy for Treatment-Naive Adults With HIV-1
- Leading Eating Disorder Treatment Center Identifies Popular Diet Myths
- Kyowa Hakko: Non-Approvable Letter for Parkinson's Treatment
- Neuroimaging Research Presented at Annual American Psychiatric Association Meeting Provides New Mechanism of Action Insight for VNS Therapy in Treatment- Resistant Depression
- Nigerian President Approves Free HIV/AIDS Treatment As Christmas Gift
- FDA Approves New Therapy for Hyperphosphatemia Patients on Dialysis
 |
 |
User Comments (0)
RSS Feeds